AAAAAA

   
Results: 1-9 |
Results: 9
EFFECTS OF ACARBOSE (GLUCOBAY(R)) IN PERSONS WITH TYPE-1 DIABETES - AMULTICENTER STUDY
Authors: SELS JPJE VERDONK HER WOLFFENBUTTEL BHR
Citation: Jpje. Sels et al., EFFECTS OF ACARBOSE (GLUCOBAY(R)) IN PERSONS WITH TYPE-1 DIABETES - AMULTICENTER STUDY, Diabetes research and clinical practice, 41(2), 1998, pp. 139-145
PROGNOSTIC FACTORS FOR SUCCESSFUL INSULIN THERAPY IN SUBJECTS WITH TYPE-2 DIABETES
Authors: WOLFFENBUTTEL BHR SELS JPJE RONDASCOLBERS GJWM MENHEERE PPCA
Citation: Bhr. Wolffenbuttel et al., PROGNOSTIC FACTORS FOR SUCCESSFUL INSULIN THERAPY IN SUBJECTS WITH TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 1387-1387
MIGLITOL (BAY-M-1099) HAS NO EXTRAINTESTINAL EFFECTS ON GLUCOSE CONTROL IN HEALTHY-VOLUNTEERS
Authors: SELS JPJE NAUTA JJP MENHEERE PPCA WOLFFENBUTTEL BHR KRUSEMAN ACN
Citation: Jpje. Sels et al., MIGLITOL (BAY-M-1099) HAS NO EXTRAINTESTINAL EFFECTS ON GLUCOSE CONTROL IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 42(4), 1996, pp. 503-506
COMPARISON OF DIFFERENT INSULIN REGIMENS IN ELDERLY PATIENTS WITH NIDDM
Authors: WOLFFENBUTTEL BHR SELS JPJE RONDASCOLBERS GJWM MENHEERE PPCA KRUSEMAN ACN
Citation: Bhr. Wolffenbuttel et al., COMPARISON OF DIFFERENT INSULIN REGIMENS IN ELDERLY PATIENTS WITH NIDDM, Diabetes care, 19(12), 1996, pp. 1326-1332
EFFECT OF MIGLITOL (BAY M-1099) ON FASTING BLOOD-GLUCOSE IN TYPE-2 DIABETES-MELLITUS
Authors: SELS JPJE KINGMA PJ WOLFFENBUTTEL BHR MENHEERE PPCA BRANOLTE JH KRUSEMAN ACN
Citation: Jpje. Sels et al., EFFECT OF MIGLITOL (BAY M-1099) ON FASTING BLOOD-GLUCOSE IN TYPE-2 DIABETES-MELLITUS, Netherlands journal of medicine, 44(6), 1994, pp. 198-201
ALPHA-GLUCOSIDASE INHIBITORS IN DIABETES - PROCEEDINGS OF A WORKSHOP HELD AT THE 27TH MEETING OF THE EUROPEAN-SOCIETY-OF-CLINICAL-INVESTIGATION - HEIDELBERG, GERMANY - 14-17-APRIL-1993 - INTRODUCTION
Authors: KRUSEMAN ACN SELS JPJE WOLFFENBUTTEL BHR
Citation: Acn. Kruseman et al., ALPHA-GLUCOSIDASE INHIBITORS IN DIABETES - PROCEEDINGS OF A WORKSHOP HELD AT THE 27TH MEETING OF THE EUROPEAN-SOCIETY-OF-CLINICAL-INVESTIGATION - HEIDELBERG, GERMANY - 14-17-APRIL-1993 - INTRODUCTION, European journal of clinical investigation, 24, 1994, pp. 1-1
IMPROVED BLOOD-GLUCOSE CONTROL BY INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS HAS NO EFFECT ON LIPOPROTEIN(A) LEVELS
Authors: WOLFFENBUTTEL BHR LEURS PB SELS JPJE RONDASCOLBERS GJWM MENHEERE PPCA KRUSEMAN ACN
Citation: Bhr. Wolffenbuttel et al., IMPROVED BLOOD-GLUCOSE CONTROL BY INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS HAS NO EFFECT ON LIPOPROTEIN(A) LEVELS, Diabetic medicine, 10(5), 1993, pp. 427-430
EFFECTS OF A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE, ON METABOLIC CONTROL IN SULFONYLUREA-TREATED PATIENTS WITH NIDDM
Authors: WOLFFENBUTTEL BHR NIJST L SELS JPJE MENHEERE PPCA MULLER PG KRUSEMAN ACN
Citation: Bhr. Wolffenbuttel et al., EFFECTS OF A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE, ON METABOLIC CONTROL IN SULFONYLUREA-TREATED PATIENTS WITH NIDDM, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 113-116
LIPOPROTEIN(A) LEVELS IN RELATION TO DIABETIC COMPLICATIONS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES
Authors: HEESEN BJ WOLFFENBUTTEL BHR LEURS PB SELS JPJE MENHEERE PPCA JACKLEBECKERS SEC KRUSEMAN ACN
Citation: Bj. Heesen et al., LIPOPROTEIN(A) LEVELS IN RELATION TO DIABETIC COMPLICATIONS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES, European journal of clinical investigation, 23(9), 1993, pp. 580-584
Risultati: 1-9 |